# HIF-1α and BMAL1 in bone regeneration: crosstalk between hypoxia response and circadian rhythm

**Authors:** Yihang Weng, Jiong Xiong, Qing Zhao, Zhen Tan

PMC · DOI: 10.1038/s41413-026-00506-8 · 2026-02-14

## TL;DR

This review explores how HIF-1α and BMAL1 work together during bone regeneration, linking hypoxia and circadian rhythms.

## Contribution

The paper provides a comprehensive review of the crosstalk between HIF-1α and BMAL1 in bone regeneration and related diseases.

## Key findings

- HIF-1α and BMAL1 regulate gene expression and downstream pathways during bone regeneration.
- The interaction between HIF-1α and BMAL1 ensures proper cellular function in hypoxic conditions.
- Their crosstalk influences bone-related diseases and offers new research directions.

## Abstract

Bone regeneration is initiated after a bone injury, such as a bone fracture or tooth extraction. It is a highly complex biological process involving multiple cell types, signaling molecules, and molecular pathways. The hypoxic microenvironment in the early stage of bone regeneration poses challenges to cell status and the final outcome of bone regeneration. During this phase, two key regulators—HIF-1α (the critical mediator of hypoxia response) and BMAL1 (the central component of the circadian rhythm)—orchestrate the activities of bone-regenerating cells, ensuring proper cellular function and orderly progression of bone repair. Existing studies have shown that there is a close crosstalk between HIF-1α and BMAL1, including regulation of gene expression, protein interaction, and regulation of downstream pathways. In this review, we discuss the respective regulatory roles of HIF-1α and BMAL1 in bone regeneration and further summarize their interactions within cells. Additionally, we extend the discussion to their interactions in other bone-related diseases, and summarize the existing research directions and deficiencies, providing new insights for in-depth studies of the hypoxia response and circadian rhythm systems.

## Linked entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], BMAL1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 406]

## Full-text entities

- **Genes:** alp (alopecia, recessive) [NCBI Gene 11691], Ctf1 (cardiotrophin 1) [NCBI Gene 13019] {aka CT-1}, Nfatc1 (nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1) [NCBI Gene 18018] {aka 2210017P03Rik, NF-ATc, NFAT2, NFATc, Nfatcb}, Pycard (PYD and CARD domain containing) [NCBI Gene 66824] {aka 9130417A21Rik, Asc, CARD5, TMS-1, TNS1, masc}, Chil3 (chitinase-like 3) [NCBI Gene 12655] {aka Chi3l3, ECF-L, Ym1}, Acan (aggrecan) [NCBI Gene 11595] {aka Agc, Agc1, CSPCP, Cspg1, b2b183Clo, cmd}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Cerk (ceramide kinase) [NCBI Gene 223753] {aka D330016D08Rik, mKIAA1646}, areg (amphiregulin) [NCBI Gene 101884611] {aka si:ch73-49h18.1}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, Cdk1 (cyclin dependent kinase 1) [NCBI Gene 12534] {aka Cdc2, Cdc2a, p34<CDC2>}, Gsdmd (gasdermin D) [NCBI Gene 69146] {aka 1810036L03Rik, DF5L, Dfna5l, GsdmD-1, Gsdmdc1, M2-4}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, BMAL2 (basic helix-loop-helix ARNT like 2) [NCBI Gene 56938] {aka ARNTL2, CLIF, MOP9, PASD9, bHLHe6}, Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, CXCR1 (C-X-C motif chemokine receptor 1) [NCBI Gene 3577] {aka C-C, C-C-CKR-1, CD128, CD181, CDw128a, CKR-1}, Smad1 (SMAD family member 1) [NCBI Gene 17125] {aka Mad1, Madh1, Madr1, Mlp1, MusMLP, dwf-A}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 12156] {aka Bmp2a}, Id1 (inhibitor of DNA binding 1, HLH protein) [NCBI Gene 15901] {aka D2Wsu140e, Idb1, bHLHb24}, Kitlg (KIT ligand) [NCBI Gene 60427] {aka Kitl, Mgf, SCF}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}, Twist2 (twist basic helix-loop-helix transcription factor 2) [NCBI Gene 13345] {aka Dermo1, bHLHa39}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, Tnfrsf11b (tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)) [NCBI Gene 18383] {aka OCIF, Opg, TR1}, Pkm (pyruvate kinase, muscle) [NCBI Gene 18746] {aka Pk-2, Pk-3, Pk3, Pkm2}, Pdlim3 (PDZ and LIM domain 3) [NCBI Gene 114108] {aka Actn2lp, Alp}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, CXCR2 (C-X-C motif chemokine receptor 2) [NCBI Gene 3579] {aka CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB}, Ldha (lactate dehydrogenase A) [NCBI Gene 16828] {aka Ldh1, Ldhm, l7R2}, Smad3 (SMAD family member 3) [NCBI Gene 17127] {aka Madh3}, Rps6kb1 (ribosomal protein S6 kinase B1) [NCBI Gene 72508] {aka 2610318I15Rik, P70S6K1, S6K, S6K-beta-1, S6K1, p70 S6K-alpha}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CLOCK (clock circadian regulator) [NCBI Gene 9575] {aka KAT13D, bHLHe8}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Sp7 (Sp7 transcription factor 7) [NCBI Gene 170574] {aka 6430578P22Rik, C22, Osx}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}, Sox9 (SRY (sex determining region Y)-box 9) [NCBI Gene 20682] {aka 2010306G03Rik, mKIAA4243, mSox9}, Bglap (bone gamma-carboxyglutamate protein) [NCBI Gene 25295] {aka Bglap2, Bgp, Bgpr, Bgpra}, Per2 (period circadian clock 2) [NCBI Gene 18627] {aka mKIAA0347, mPer2}, Aass (aminoadipate-semialdehyde synthase) [NCBI Gene 30956] {aka LKR, LKR/SDH, LOR, LOR/SDH, Lorsdh, SDH}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 26419] {aka JNK, JNK1, Prkm8, SAPK1}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 54250] {aka Fgf-2, Fgf2a, bFGF}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Cxcl12 (C-X-C motif chemokine ligand 12) [NCBI Gene 24772] {aka Sdf1}, Mmp8 (matrix metallopeptidase 8) [NCBI Gene 17394], Angpt1 (angiopoietin 1) [NCBI Gene 89807] {aka Agpt, Agpt1, Ang-1}, Lyz2 (lysozyme 2) [NCBI Gene 17105] {aka Lys, Lysm, Lyzf2, Lyzs, Lzm, Lzm-s1}, ARNT2 (aryl hydrocarbon receptor nuclear translocator 2) [NCBI Gene 9915] {aka WEDAS, bHLHe1}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, hif1al2 (hypoxia inducible factor 1 subunit alpha, like 2) [NCBI Gene 497283] {aka hif1al, zgc:112119}, EPAS1 (endothelial PAS domain protein 1) [NCBI Gene 2034] {aka ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73}, Bmp4 (bone morphogenetic protein 4) [NCBI Gene 12159] {aka Bmp-4, Bmp2b, Bmp2b-1, Bmp2b1}, Ang2 (angiogenin, ribonuclease A family, member 2) [NCBI Gene 11731] {aka Angrp, Raa3, Rnase5b}, ARNT (aryl hydrocarbon receptor nuclear translocator) [NCBI Gene 405] {aka ARNT1, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, Spp1 (secreted phosphoprotein 1) [NCBI Gene 20750] {aka 2AR, Apl-1, BNSP, BSPI, Bsp, ETA-1}, cyc (cycle) [NCBI Gene 40162] {aka BMAL1, Bmal1, CG8727, CYCLE, Cycle, Dmel\CG8727}
- **Diseases:** circadian rhythm disorder (MESH:D021081), metabolic abnormalities (MESH:D008659), OA (MESH:D010003), arrhythmic (OMIM:212500), Cartilage degeneration (MESH:D002357), Hypoxia (MESH:D000860), abnormal BMD (MESH:D001851), obesity (MESH:D009765), bleeding (MESH:D006470), Hypoxic (MESH:D002534), DM (MESH:D003920), ischemic (MESH:D002545), vascular disruption (MESH:D019958), degenerative joint disorder (MESH:D019636), trauma (MESH:D014947), inflammation (MESH:D007249), glioma (MESH:D005910), hematoma (MESH:D006406), Hyperglycemia (MESH:D006943), bone fracture (MESH:D050723), diabetic nephropathy (MESH:D003928), liver cancer (MESH:D006528), condylar deformity (MESH:C538270), impaired glucose tolerance (MESH:D018149), necrotic (MESH:D009336), tooth extraction (MESH:D014076), type 2 diabetes (MESH:D003924), OSA (MESH:D020181), mandibular defects (MESH:D008338), beta-cell dysfunction (MESH:D007340), myocardial infarction (MESH:D009203), coagulation (MESH:D001778), cardiovascular disease (MESH:D002318), hypertrophy (MESH:D006984), diabetic retinopathy (MESH:D003930), temporomandibular joint OA (MESH:D013706), knee OA (MESH:D020370), bone defects (MESH:D001847), joint diseases (MESH:D007592), Osteoporosis (MESH:D010024), insulin resistance (MESH:D007333), hip and wrist fractures (MESH:D000092503), colorectal cancer (MESH:D015179)
- **Chemicals:** blood sugar (MESH:D001786), ED-71 (MESH:C547512), lactate (MESH:D019344), TCA (MESH:D014233), pentose phosphate (MESH:D010428), pyruvate (MESH:D019289), Succinate (MESH:D019802), adenosine (MESH:D000241), vitamin D (MESH:D014807), O2 (MESH:D010100), 1,25(OH)2D3 (MESH:D002117), CoCl2 (MESH:C018021), glucose (MESH:D005947), pO2 (MESH:C093415), calcium (MESH:D002118), ROS (MESH:D017382), ATP (MESH:D000255), glutathione (MESH:D005978), Co2+ (MESH:D002245), LPS (MESH:D008070), Titanium (MESH:D014025), fatty acids (MESH:D005227), Ca2+ (-), melatonin (MESH:D008550)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955]
- **Mutations:** glutamine into glutamate
- **Cell lines:** U2OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042), RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), MC3T3-E1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0409), OC — Homo sapiens (Human), Ovarian serous cystadenocarcinoma, Cancer cell line (CVCL_A1GZ)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12906504/full.md

---
Source: https://tomesphere.com/paper/PMC12906504